How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey

Verfasser / Beitragende:
[Yoshihito Yokoyama, Kiyoshi Ito, Kiyoshi Takamatsu, Kazuhiro Takehara, Toru Nakanishi, Kenichi Harano, Hidemichi Watari, Nobuyuki Susumu, Daisuke Aoki, Toshiaki Saito]
Ort, Verlag, Jahr:
2015
Enthalten in:
International Journal of Clinical Oncology, 20/5(2015-10-01), 997-1004
Format:
Artikel (online)
ID: 605491488
LEADER caa a22 4500
001 605491488
003 CHVBK
005 20210128100510.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s10147-015-0808-5  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10147-015-0808-5 
245 0 0 |a How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey  |h [Elektronische Daten]  |c [Yoshihito Yokoyama, Kiyoshi Ito, Kiyoshi Takamatsu, Kazuhiro Takehara, Toru Nakanishi, Kenichi Harano, Hidemichi Watari, Nobuyuki Susumu, Daisuke Aoki, Toshiaki Saito] 
520 3 |a Background: This survey sought to determine Japanese gynecologists' attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Methods: Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Results: Responses from 363 individuals (response rate 40.9%) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46% of physicians in Germany (P<0.0002). Forty-nine percent of Japanese physicians approved of prescribing HRT for patients with high risk of recurrence vs. 25% of physicians in Germany (P<0.0001). Conclusion: Many Japanese gynecologists have a favorable attitude toward prescribing HRT after treatment of EC. 
540 |a Japan Society of Clinical Oncology, 2015 
690 7 |a Endometrial cancer  |2 nationallicence 
690 7 |a Hormone replacement therapy  |2 nationallicence 
690 7 |a Japanese gynecologists attitude  |2 nationallicence 
690 7 |a Anonymous questionnaire  |2 nationallicence 
700 1 |a Yokoyama  |D Yoshihito  |u Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan  |4 aut 
700 1 |a Ito  |D Kiyoshi  |u Department of Disaster Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, 980-8573, Sendai, Miyagi, Japan  |4 aut 
700 1 |a Takamatsu  |D Kiyoshi  |u Department of Obstetrics and Gynecology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Chiba, Japan  |4 aut 
700 1 |a Takehara  |D Kazuhiro  |u Department of Gynecologic Oncology, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan  |4 aut 
700 1 |a Nakanishi  |D Toru  |u Department of Gynecology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan  |4 aut 
700 1 |a Harano  |D Kenichi  |u Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan  |4 aut 
700 1 |a Watari  |D Hidemichi  |u Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan  |4 aut 
700 1 |a Susumu  |D Nobuyuki  |u Department of Obstetrics and Gynecology, School of Medicine, Keio University, Shinjuku, Tokyo, Japan  |4 aut 
700 1 |a Aoki  |D Daisuke  |u Department of Obstetrics and Gynecology, School of Medicine, Keio University, Shinjuku, Tokyo, Japan  |4 aut 
700 1 |a Saito  |D Toshiaki  |u Gynecology Service, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Fukuoka, Japan  |4 aut 
773 0 |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 997-1004  |x 1341-9625  |q 20:5<997  |1 2015  |2 20  |o 10147 
856 4 0 |u https://doi.org/10.1007/s10147-015-0808-5  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10147-015-0808-5  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yokoyama  |D Yoshihito  |u Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ito  |D Kiyoshi  |u Department of Disaster Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, 980-8573, Sendai, Miyagi, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Takamatsu  |D Kiyoshi  |u Department of Obstetrics and Gynecology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Chiba, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Takehara  |D Kazuhiro  |u Department of Gynecologic Oncology, National Hospital Organization, Shikoku Cancer Center, Matsuyama, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nakanishi  |D Toru  |u Department of Gynecology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Harano  |D Kenichi  |u Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Watari  |D Hidemichi  |u Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Susumu  |D Nobuyuki  |u Department of Obstetrics and Gynecology, School of Medicine, Keio University, Shinjuku, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Aoki  |D Daisuke  |u Department of Obstetrics and Gynecology, School of Medicine, Keio University, Shinjuku, Tokyo, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Saito  |D Toshiaki  |u Gynecology Service, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Fukuoka, Japan  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t International Journal of Clinical Oncology  |d Springer Japan  |g 20/5(2015-10-01), 997-1004  |x 1341-9625  |q 20:5<997  |1 2015  |2 20  |o 10147